dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Kiri

Sotsiaalministeerium · 6. juuli 2020
Viit
1.4-2/2137-1
Registreeritud
6. juuli 2020
Dokumendi liik
Sissetulev kiri
Adressaat
World Health Organization
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2020
Vastutaja
Elen Ohov (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)

Failid

  • 📎C.L.22.2020 Corrigendum English.pdf299 KB
  • 📎E-kiri.pdf65 KB

Sisu (failidest)

20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT Ref.: C.L.22.2020 Corr.1 The World Health Organization (WHO) presents its compliments to Member States and Associate Members and has the honour to refer to the note verbale C.L.22.2020 dated 23 June 2020. ... Annex II of note verbale C.L.22.2020 has been updated and is attached to C.L.22.2020 Corr.1. The World Health Organization takes this opportunity to renew to Member States and Associate Members the assurance of its highest consideration. GENEVA, 1 July 2020 ... ENCL.: (1) Annex 2 List of focal points designated by Member States in previous years Country E-mail Name Focal Point Position Affiliation Comments Afghanistan [email protected] Shahpoor Yousuf Albania [email protected] Linda Ternova Specialist Regulation Sector of Pharmaceutical Market and Medical Devices Algeria [email protected] Ghrieb Houria Chargé du dossier des stupéfiants, des psychotropes et des précurseurs chimiques Andorra [email protected] Carla Lobaco Valls Technical officer Department of Health Resources and Medicines Andorra [email protected] Carme Pallarés Chief Department of Health Papaseit Resources and Medicines Angola Antigua and Barbuda Argentina [email protected] G. Rebaldería Psicotrópicos Administración Nacional de Medicamentos, Alimentos y Tecnología Armenia [email protected] Hasmik Martirosyan Head Controlled Substances Management Department Australia [email protected] Allison Jones Australia [email protected] Leila Jordan Director UN Health Section, International and Commonwealth/State Relations Branch, Australian Government Department of Health Austria [email protected] Mag Raphael Bayer Deputy Head Federal Ministry of Labour, Social Affairs, Health, and Consumer Protection 1 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Azerbaijan [email protected] Telman Suleyman Oglu Mammadhassanov Bahamas Bahrain [email protected] Samar Yousef Salem Bangladesh [email protected] Md. Habibur Rahman Addl. Secretariat, Health Please confirm Khan Services Division, Ministry email address of Health and Family Welfare Barbados [email protected] Maryam Hinds Director Barbados Drug Service b Belarus [email protected] Aleksey Kralko Belgium [email protected] Peter Blankaert Epidemiology and public health Belize Benin [email protected] Hope Akohouvi Amou Pharmacien Diplômé Direction de la Pharmacie, d’Etat du Médicament et des Explorations Diagnostiques Bhutan [email protected] Dil Kumar Subba Bolivia (Plurinational State of) [email protected] Maria Julia Carrasco Bosnia and Herzegovina [email protected] Ana Cvijanović Bosnia and Herzegovina [email protected] Sabina Šahman Please confirm email address Botswana [email protected] Vivian Sebako Chief Pharmacist Department of Clinical Services Brazil [email protected] Maria Dilma Alves Teodoro 2 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Brazil [email protected] General Coordinator for Mental Health, Alcohol and other drugs Brazil [email protected] Renata de Morais Controlled products National Health Surveillance Souza manager Agency (Anvisa) Brazil [email protected] Controlled products National Health Surveillance Exceeds limit of manager Agency (Anvisa) 3 focal points Brunei Darussalam [email protected] Hajah Rosni Haji Jair Director of Pharmaceutical Services Bulgaria [email protected] Slaveyka Nikolova Senior Expert at the ‘Health Promotion and Prophylaxis of Diseases and Addictions’ Bulgaria [email protected] Director National Focal Centre in the National Centre of Narcotic Addictions Burkina Faso [email protected] Burundi [email protected] Aimable Bizoza Cabo Verde [email protected] Fernanda Marques Cambodia [email protected] Chhit Sophal Cameroon [email protected] Ketchozo Loko Chef de Bureau des Please confirm Wilfried Stupéfiants et des email address Psychotropes Canada hc.csd.international.dsc.sc@canad a.ca Central African Republic 3 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Chad [email protected] Haoua Haroun Saker Please confirm email address Chile [email protected] Javiera Erazo Leiva Psicóloga China [email protected] Deputy Director of National Narcotics Division II Laboratory China [email protected] Wang Wei Officers from Office of National Narcotics International Control Commission Cooperation Division China [email protected] Senior Expert National Narcotics Laboratory Colombia [email protected] Oscar Ricardo Santana Please confirm email address Colombia [email protected] Coordinadora del Ministerio de Salud Grupo de Convivencia Social y Ciudadanía de la Dirección de Promoción y Prevención Colombia [email protected] A. Peñuela Please confirm email address Comoros Congo [email protected] Ghislaine Mbelu Pharmacist Kanyunya Cook Islands [email protected] Valentino Wichman ov.ck 4 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Costa Rica [email protected] Marchena Vasquez MD, External institute on alcoholism and consultation, drug dependence comprehensive care center for minors Côte d’Ivoire [email protected] Ernest Zotoua Directeur Coordonnateur du Programme National de Lutte contre le Tabagisme, la Toxicomanie et les autres Addictions Croatia [email protected] Romana Katalinić Cuba Cyprus [email protected] John Kkolos Czechia [email protected] Vlastimil Brandejs Unit of the Narcotics and Psychotropic Substances Inspectorate Democratic People’s Republic Kim Jong Guk Section Chief, Drug of Korea Supply and Management department Democratic Republic of the Congo Denmark [email protected] Maria Koch Aabel Danish Health Authority Djibouti Dominica Dominican Republic [email protected] Elizabeth Ruiz Please confirm email address Dominican Republic dalia.sanchez@ministeriodesalud. Francisca Dalia Please confirm gob.do Castillo Sanchez email address 5 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Ecuador [email protected] Enríquez Anaya Internal Management of Mental Health and Integral Prevention of the Socioeconomic Phenomenon of Drugs Area Ecuador [email protected] Rojeab Bravo Analyst of the transition process of the "Drugs Technical Secretariat" into a Ministry of Health attribution Egypt [email protected] Nahla Attia Ministry of Health Egypt El Salvador [email protected] José Mauricio Bermúdez Recinos Equatorial Guinea Eritrea [email protected] Michael Girmay Haile Estonia [email protected] Malle Tiidelepp Please confirm email address Estonia Katrin.Tomson- Katrin Tomson- Leading Specialist of Agency of Medicines of [email protected] Johanson Department of Estonia Inspection Eswatini Ethiopia [email protected] Baharu Zewdie Moya Drug Dependency Prevention and Control Fiji [email protected] Apolosi Vosanibola Finland [email protected] Katja Pihlainen France [email protected] Aldine Fabreguettes 6 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Gabon [email protected] Okouyi Ndakissa Senior Specialist, Department of Pharmaceutical Activities Gambia Georgia [email protected] Ketevan Gorozia Germany [email protected] Elke Lehmann Ghana [email protected] Martha Gyansa- Director, Lutterodt Pharmaceutical Services Greece [email protected] Ioanna Siamou Grenada Guatemala [email protected] Erica Janeth Cohobon Departamento de Lepe Regulacion y control de productos farmeuticos y afines Guinea Guinea-Bissau Guyana Haiti [email protected] Marie Judith Robuste Chef de Service Roche Honduras [email protected] Alex Virgilio Santos Director General Instituto Hondureño para la Moreno Prevención del Alcoholismo, Drogadicción y Farmacodependencia Hungary [email protected] Tímea Kahlesz Iceland [email protected] Bjarni Sigurðsson Pharmacist Ministry of Health India [email protected]), Rakesh Chadda 7 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Indonesia [email protected] Dra Agusdini Banun Saptaningsih Iran (Islamic Republic of) [email protected] Abdehzadeh Iran (Islamic Republic of) [email protected] Alebouyeh Iran (Islamic Republic of) [email protected] Ahmad Hajebi Director General of Iran University of medical Department for Mental sciences, department of Health & Substance psychiatry; ReCARB Abuse Iraq [email protected] Abdulghani National Advisor for Please confirm mental health/ email address Consultant Psychiatrist Ireland [email protected] Brennan Assistant Principal, Department of Health Ireland [email protected] Byran Sheehan Higher Executive Officer, Department of Health Israel [email protected] Itamar Grotto Head of Public Health Ministry of Health Services Israel [email protected] Tal Lavy The Component Authority for Narcotics, Psychotropics, and Precursors Israel [email protected] Adviser Permanent Mission of Israel to the UN, Geneva Italy [email protected] Pietro Canuzzi Directorate General for Health Prevention Italy [email protected] Rocco Signorile Ministry of Health Jamaica [email protected] Lishann Salmon Ministry of Health; Ministry of Foreign Affairs and Foreign Trade; Permanent Mission of Jamaica to the United Nations, Geneva 8 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Jamaica [email protected] Winston De La Haye Jamaica [email protected] Michelle Walker Japan [email protected] Compliance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau Jordan [email protected] Heyam Wahbeh Kazakhstan [email protected] Prilutskaya Marina Kenya [email protected] Anthony Toroitich g Kenya [email protected] Simon Njuguna Kiribati [email protected] Biribo Kararaiti Kuwait [email protected] Ali Abdulmohsen Jaragh Kyrgyzstan [email protected] Kanyshai Damirbek Lao People’s Democratic [email protected] Khatthanaphone Head of Health Please confirm Republic Phandoangsy Promotion and email address Nutrition Unit Latvia [email protected] Linda Veisberga Lebanon [email protected] Marie-Therese Matar Lesotho [email protected] Masello Sello Liberia Libya Lithuania [email protected] Rima Mačiūnienė Head of the Drugs and Psychotropic Substances Precursors Control and Risk Assessment Division 9 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Luxembourg [email protected] Alain Origer Madagascar [email protected] Mahavany Vénot Pharmacien Inspecteur Amélie Nicole Malawi [email protected] Michael Udedi Assistant Director of Please confirm Clinical Services email address (Mental health and substance abuse) Malaysia [email protected] Rohaida Binti Zakaria Senior Principle Ministry of Health Assistant Director Licensing Branch (Controlled Sub- Section), Pharmacy Enforcement Division Maldives [email protected] Aishath Mohamed Deputy Director General, Pharmaceuticals; Medicine and Therapeutic Goods Division Mali [email protected] Mahamadou Ousmane Chef de Section Direction de la Pharmacie Maiga Reglementation Malta [email protected] Victor P. Pace Marshall Islands [email protected] Julia Alfred Secretary of Health Please confirm email address Mauritania [email protected] Hamoud Fadel Directeur de la Ministère de la Santé Yamohomed Pharmacie et du Laboratoire Mauritius [email protected] Director health Services (DHS) Mauritius [email protected] A. Jhugroo Adviser, Substance Abuse 10 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Mexico [email protected] David Correa Pina Verificador- Dictaminador Especializado Micronesia (Federated States [email protected] Benido Victor of) Monaco [email protected] Isabelle Kessedjian Mongolia [email protected] Luvsandagva Purevdorj Montenegro [email protected] Jasna Sekulic Head of the Department for prevention policy of drug abuse Morocco [email protected] Hassan Elkarimi Morocco [email protected] Jallal Toufiq Directeur, OMDA, CHU Ar-Razi, Salé Mozambique [email protected] Eugénia Guelfrida Salesio Teodoro Myanmar [email protected] Nanda Myo Aung Program Drug Dependency Wan Manager/Consultant Treatment and Research Psychiatrist Unit, Department of Medical Services Myanmar [email protected] Tin Wah Wah Win Deputy Director (Drugs) / Department of Food and Drug Administration Namibia [email protected] Ester Mvula Nauru [email protected] Richard Leona Nepal Netherlands [email protected] Liefke Huizinga New Zealand [email protected] Emily Kay 11 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments New Zealand [email protected] Lauren Bellamore Advisor (Drug Ministry of Health Intelligence) Nicaragua [email protected] Karla Vanessa Directora de Farmacia Delgado Martinez Niger [email protected] Haoua Na Allah Alou Chef de Division la Direction de la Pharmacie Pharmacie et et de la Medecine Medicaments Traditionnelle au Ministere de la Sante Publique Nigeria [email protected] Rafiu Akanbi Folarin Head Narcotics and Please confirm Drug Abuse email address Niue [email protected] Grizelda Mokoia North Macedonia Norway [email protected] Anne S. Onsgård Sagabråten Oman [email protected] Mahmood Al Abri Pakistan [email protected] Muhammad Arif Palau [email protected] Chief Pharmacist, Chief of Ancillary Services Palau [email protected] Palau [email protected] Marla Ito Panama Papua New Guinea [email protected] Vicky Wari Paraguay Peru [email protected] Judith Castañeda Alcántara Philippines [email protected] Ivanhoe Escartin 12 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Poland [email protected] Michał Kidawa National Bureau for Drug Prevention Portugal [email protected] Graça Vilar Consultant Psychiatrist Puerto Rico Qatar [email protected] Majid Ali Al Abdulla Republic of Korea [email protected] Mi Young Hyun Republic of Moldova [email protected] Stanislav Grosu Romania [email protected] Camelia Bunaciu Russian Federation [email protected] Olga Panova Deputy Head of Ministry of Health Division, Department of Drug Supply and Medical devises regulation Rwanda Saint Kitts and Nevis Saint Lucia [email protected] Donna Daniel Please confirm email address Saint Lucia [email protected] Paul Caleb Programme Officer, Substance Abuse Unit, Department of Health and Wellness Saint Vincent and the Grenadines Samoa [email protected] Robert Thomsen San Marino Sao Tome and Principe Saudi Arabia [email protected] Adnan Alshammary Saudi Food and Drug Authority 13 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Senegal [email protected] Bintou Dia Serbia [email protected] Nataša Savić Seychelles Sierra Leone Singapore [email protected] Ong Lay Tin Senior Executive Ministry of Health (International Cooperation) / Public Health Group Slovakia [email protected] Jan Lehotsky Reitox National FP, Ministry of Health Department of Anti- Drug Strategy Coordination and Drug Monitoring Slovenia [email protected] Joze Hren Solomon Islands [email protected] Paul Orotaloa Solomon Islands [email protected] Stephen Araitewa Somalia South Africa [email protected] MG Molewa Deputy Director Inspectorate & Law Enforcement South Sudan Spain [email protected] Manuel Ibarra Jefe de Departamento Agencia Española de de Inspección y Medicamentos y Productos Control de Sanitarios Medicamento Spain [email protected] Lidia Fernandez Jefe del Área de Agencia Española de Matellano Estupefacientes y Medicamentos y Productos Psicótropos Sanitarios Sri Lanka [email protected] BMW Balasooriya 14 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Sudan Suriname Sweden david.lorentzon@regeringskansliet David Lorentzon .se Switzerland [email protected] Diane Steber Syrian Arab Republic [email protected] Ahmed Al-Salama Directorate of Mental Health Tajikistan [email protected] Salim Abdulazizov Thailand [email protected] Chantharakul Pharmacist in Narcotics Control Division Professional Level (Standards and Regulations Sub-Division), Food And Drug Administration, Ministry of Public Thailand [email protected] Chavanich Pharmacist in Narcotics Control Division Professional Level (Standards and Regulations Sub-Division), Food And Drug Administration, Ministry of Public Thailand [email protected] Tontisirin Director of Narcotics Narcotics Control Division, Control Division Food And Drug Administration, Ministry of Public Health Timor-Leste [email protected] Soares Henriques Official at the National Directorate for Department of Pharmacy and Medicine Authorisation and Market's Introduction Togo [email protected] Mouhoudine Yerima Responsable de la Please confirm pharmacovigilance email address Tokelau Tonga [email protected] Melenaite Mahe 15 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments Trinidad and Tobago [email protected] Rohit Doon Advisor, Health Promotions and Communications Tunisia Turkey [email protected] Demet Head of Department Aydınkarahaliloğlu for Pharmacovigilance and the Substances subject to control Turkmenistan Tuvalu Uganda [email protected] Hafsa Lukwata Senior Medical Officer Ukraine [email protected] Liudmyla Deputy Director of the Ministry of Health of Konoshevych State Agency "The Ukraine Center for Mental Health Monitoring of Drugs and Alcohol" Ukraine [email protected] Viktoria Kurlova Head of the Ministry of Health of Department of Ukraine National Strategy and Policy on the Circulation of Psychoactive Substances of the State Agency "Center for Mental Health Monitoring of Drugs and Alcohol" Ukraine [email protected] Sergii Shum State Agency "The Center for Mental Health Monitoring of Drugs and Alcohol" United Arab Emirates 16 Annex 2 Country E-mail Name Focal Point Position Affiliation Comments United Kingdom of Great [email protected] Catherine Crawford Britain and Northern Ireland United Kingdom of Great [email protected] Martin White Britain and Northern Ireland United Republic of Tanzania [email protected] Sara Maongezi United States of America [email protected] Jim Hunter Senior Program Center for Drug Evaluation Manager Controlled & Research Substances Uruguay [email protected] Horacio Porciuncula Area programatica de salud mental Uzbekistan Vanuatu [email protected] Jerry Iaruel Venezuela (Bolivarian Republic of) Viet Nam [email protected] Mhin Tam Nguyen Head of Prevention Ministry of Health Department, Viet Nam Authority for HIV/AIDS Control Yemen Zambia [email protected] Nita Besa Please confirm email address Zimbabwe [email protected] Eneti Siyame Mental Health Manager 17 Saatja: <[email protected]> Saadetud: 03.07.2020 17:06 Koopia: <[email protected]> Teema: WHO: C.L.22.2020 Corr.1 (43 ECDD) Dear Member States of the World Health Organization,Please find attached, in the six official languages, C.L.22.2020 Corr.1 regarding the 43rd Expert Committee on Drug Dependance which will be held from 12 to 16 October 2020.Best regards,Department of Governing BodiesWorld Health Organization
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel